Here's how I think the CSL share price might end 2024

MotleyFool08-11

The CSL Ltd (ASX: CSL) share price sold off sharply earlier this week but has since staged a recovery. At Friday's close, the biotech giant was trading at $308 per share, up more than 4% over the past...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2458631835?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-11 05:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2458631835","market":"us","top_or_hot":-1,"title":"Here's how I think the CSL share price might end 2024","media":"MotleyFool","content":"<div>\n<p>The CSL Ltd (ASX: CSL) share price sold off sharply earlier this week but has since staged a recovery. At Friday's close, the biotech giant was trading at $308 per share, up more than 4% over the past...</p>\n\n<a href=\"https://www.fool.com.au/2024/08/11/heres-how-i-think-the-csl-share-price-might-end-2024/\">Source Link</a>\n\n</div>\n","source":"motleyfoolau_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's how I think the CSL share price might end 2024</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's how I think the CSL share price might end 2024\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-11 05:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com.au/2024/08/11/heres-how-i-think-the-csl-share-price-might-end-2024/><strong>MotleyFool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The CSL Ltd (ASX: CSL) share price sold off sharply earlier this week but has since staged a recovery. At Friday's close, the biotech giant was trading at $308 per share, up more than 4% over the past...</p>\n\n<a href=\"https://www.fool.com.au/2024/08/11/heres-how-i-think-the-csl-share-price-might-end-2024/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CSL","symbol_name":"卡莱尔伙伴","start_time":0,"source_url":"https://www.fool.com.au/2024/08/11/heres-how-i-think-the-csl-share-price-might-end-2024/","article_id":"2458631835","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2458631835","pubTimestamp":1723323600,"sourceInfo":{"source_id":"motleyfoolau_stock","name":"MotleyFool"},"weMediaInfo":null,"summary":"The CSL Ltd (ASX: CSL) share price sold off sharply earlier this week but has since staged a recovery. At Friday's close, the biotech giant was trading at $308 per share, up more than 4% over the past","collect":0,"end_time":0,"defaultTopTitle":"fool.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"CSL":"卡莱尔伙伴","BK7508":"医药生物股","CSL.AU":"CSL LIMITED","BK4086":"建筑产品","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","SWAN":"Amplify BlackSwan Growth & Treasury Core ETF","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","LU0728928796.USD":"abrdn SICAV I - GLOBAL SMALL&MID-CAP SDG HORIZONS EQUITY \"A\" (USD) ACC","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","BK7067":"生物科技","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","BK7511":"ESG概念","BK7501":"新冠治疗股"},"translate_title":"我认为CSL股价可能会在2024年结束","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSL":1,"CSL.AU":1,"SWAN":1},"content_text":"The CSL Ltd (ASX: CSL) share price sold off sharply earlier this week but has since staged a recovery. At Friday's close, the biotech giant was trading at $308 per share, up more than 4% over the past month. Analysts believe the biotech giant could end the year on a high note. Here's what I see for the CSL shared based on the expert's opinions.   Why CSL could finish strong in 2024 CSL is one of the best-known stocks on the ASX, so any information or updates on the company are usually digested fairly quickly. And while things have been quiet from the company's end lately, it's been anything but from the crowd of analysts covering the stock. Bell Potter recently issued a buy rating with a price target of $327.42 on the CSL share price.  According to my colleague James, the broker reckons that CSL's current share price offers an attractive entry point, especially compared to historical averages. At the time of its report, CSL was trading at a forward price-to-earnings (P/E) ratio of around 28 times. This is below its 10-year average of 31 times and well under its five-year average of 35 times, Bell Potter says. The broker notes this disconnection could create a solid buying opportunity, adding that CSL might be on the verge of a \"margin recovery phase\". Macquarie also has a buy rating on CSL, with a price target of $330, whilst consensus also sees it as a buy, according to CommSec.  Fundamentals shine amid volatility CSL stands out as a 'sleep-well-at-night' (SWAN) stock in the healthcare sector, in my opinion. Healthcare is a defensive industry, and companies like CSL tend to be resilient during economic downturns. For instance, during the COVID-19 recession, CSL continued to deliver steady revenue, showcasing its stability. Another strength is CSL's long history of generating high returns on capital. In the first half of FY24, CSL reported an 11% increase in revenue to US$8.05 billion. Net profits were up 20% to US$1.94 billion. CSL's financial position is expected to strengthen further. Bell Potter anticipates that CSL will continue to reduce its debt.  Meanwhile, UBS forecasts earnings per share (EPS) are expected to reach roughly AUD$9.45.  Here I will take a more conservative P/E ratio than where CSL trades today of 35 times. If investors pay this multiple, this could see the CSL share price rise to around $330 per share by year-end. If they continue paying the current 38 times, the share price could be $359, according to UBS' estimates (38 x 9.45 = $359). CSL share price snapshot Based on broker opinions and a range of valuation multiples, my estimation is that the CSL share price could trade between $330 and $359 per share by the end of this year. CSL shares are up 16% in the past 12 months.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2458631835"}